GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly development in how we handle high blood sugar. These injectable drugs help mimicking the body’s inherent GLP-1 process, https://hotbookmarkings.com/story21739591/glp-1-a-major-advance-in-diabetes-care